View Post

Immunocompromised Pediatric Patients Showed T-cell Activity and Humoral Immunity Against SARS-CoV-2

In COVID-19, Latest News by Precision Vaccinations

According to data from a recent study of adult and pediatric patients with antibody deficiencies, patients that often fail to make protective immune responses to infections and vaccinations showed robust T-cell activity and humoral immunity against SARS-CoV-2 structural proteins.
The new study published on May 13, 2021, led by researchers at Children’s National Hospital, is the first to demonstrate a robust T-cell response against SARS-CoV-2 in immunocompromised patients.